A shared goal to raise awareness and develop better treatments for neonatal-onset epilepsy has brought Baylor College of Medicine researchers together with three U.S. families.
A team of researchers shows Food and Drug Administration (FDA)-approved compounds can stop cancer growth and can potentially lead to the discovery of drugs in a way that is quicker and less expensive than traditional drug development strategies.
Researchers from Baylor College of Medicine are working on developing a flexible, parent-led cognitive-behavioral intervention for children with autism spectrum disorder and anxiety.
Researchers have shown that a particular treatment significantly reduced cardiovascular events, including cardiovascular death, in patients who continue to have high triglyceride levels on statin therapy.
To find the right cure for blood vessel diseases, researchers are working to design technology to predict the workings of vascular diseases and responses to drugs at a patient-specific level.
Dr. Tao Wu recently joined the Department of Molecular and Human Genetics at Baylor College of Medicine as an assistant professor through a $2 million recruitment grant from the Cancer Prevention and Research Institute of Texas (CPRIT).
To gain insight into the patient perspective on diagnostic errors, researchers from Baylor College of Medicine conducted a study to identify factors that could contribute to diagnostic error, specifically those related to patient-physician interaction.
A team led by researchers at Baylor College of Medicine has uncovered an unexpected mechanism that can explain a form of Batten disease called neuronal ceroid lipofuscinosis 8.
